CARLSBAD, Calif. -- Senté, medical-grade skincare company, announced the renewal of its Chief Scientific Advisor agreement with Richard Gallo M.D. The renewal extends a longstanding partnership that has helped shape the company's scientific foundation and clinical direction since it was created.
Gallo, a globally recognized leader in dermatology and skin biology, has served as a key scientific advisor to Senté from the beginning and played a central role in the research and development of the company's patented Heparan Sulfate Analog (HSA) technology. He also led the pivotal studies that support the clinical efficacy of Senté's proprietary HSA molecule, and helped establish the scientific credibility behind the brand's clinically proven formulations. Senté's patented HSA technology is designed to support skin repair and rejuvenation by helping restore healthy skin function and reduce visible signs of inflammation and aging.
"I am proud to continue my partnership with Senté and support the company's mission to advance skincare through rigorous science and clinically meaningful innovation. Senté's commitment to research and evidence-based product development continues to differentiate the brand within the professional skincare market," Gallo said.
Gallo is internationally recognized for his research in dermatology, immunology, and skin defense mechanisms, and currently serves as Distinguished Professor and Founding Chair of the Department of Dermatology at the University of California San Diego.
Under the renewed agreement, Gallo will continue to advise Senté on its clinical research initiatives, product innovation pipeline, and broader scientific strategy as the company advances next-generation skincare solutions grounded in regenerative skin science.
"Dr. Gallo's contributions to Senté have been foundational to who we are as a science-driven skincare company," said Zubin Meshginpoosh, President and CEO of Senté. "His expertise, leadership, and pioneering work around skin immunity and repair have helped validate our patented HSA technology and continue to guide our innovation efforts as we expand our clinical and development programs."
Senté's mission is to pioneer regenerative skincare through biomimetic science, delivering gentle, highly tolerable formulations suited for even the most sensitive skin, tested on all skin tones, and vetted by medical professionals. The company maintains a deep commitment to scientific rigor, clinical integrity, and the physicians and practices it supports.
